Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis.
Graille-Avy L, Boutiere C, Rigollet C, Perriguey M, Rico A, Demortiere S, Durozard P, Hilezian F, Vely F, Bertault-Peres P, Pelletier J, Maarouf A, Audoin B. Graille-Avy L, et al. Among authors: hilezian f. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200231. doi: 10.1212/NXI.0000000000200231. Epub 2024 Apr 16. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38626360 Free PMC article.
Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis.
Demortiere S, Joubert B, Benaiteau M, Hilezian F, Boutiere C, Rico A, Stolowy N, Dubois V, Audoin B, Maarouf A, Pelletier J. Demortiere S, et al. Among authors: hilezian f. Neurology. 2024 Apr 23;102(8):e209284. doi: 10.1212/WNL.0000000000209284. Epub 2024 Mar 25. Neurology. 2024. PMID: 38527243 No abstract available.
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?
Claverie R, Perriguey M, Rico A, Boutiere C, Demortiere S, Durozard P, Hilezian F, Dubrou C, Vely F, Pelletier J, Audoin B, Maarouf A. Claverie R, et al. Among authors: hilezian f. Neurol Neuroimmunol Neuroinflamm. 2023 Aug 21;10(5):e200152. doi: 10.1212/NXI.0000000000200152. Print 2023 Sep. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37604695 Free PMC article.
Disease Evolution in Women With Highly Active MS Who Suspended Natalizumab During Pregnancy vs Rituximab/Ocrelizumab Before Conception.
Demortiere S, Maarouf A, Rico A, Boutiere C, Hilezian F, Durozard P, Pelletier J, Audoin B. Demortiere S, et al. Among authors: hilezian f. Neurol Neuroimmunol Neuroinflamm. 2023 Aug 7;10(5):e200161. doi: 10.1212/NXI.0000000000200161. Print 2023 Sep. Neurol Neuroimmunol Neuroinflamm. 2023. PMID: 37550074 Free PMC article.
TNF-α inhibitors used as steroid-sparing maintenance monotherapy in parenchymal CNS sarcoidosis.
Hilezian F, Maarouf A, Boutiere C, Rico A, Demortiere S, Kerschen P, Sene T, Bensa-Koscher C, Giannesini C, Capron J, Mekinian A, Camdessanché JP, Androdias G, Marignier R, Collongues N, Casez O, Coclitu C, Vaillant M, Mathey G, Ciron J, Pelletier J, Audoin B; Under the aegis of the French Multiple Sclerosis Society. Hilezian F, et al. J Neurol Neurosurg Psychiatry. 2021 Jun 8;92(8):890-6. doi: 10.1136/jnnp-2020-325665. Online ahead of print. J Neurol Neurosurg Psychiatry. 2021. PMID: 34103339 Free PMC article.